FBN1 Gene Weill-Marchesani Syndrome Dominant Type 2 Genetic Test sale cost 4400 AED
LRIG2 Gene Urofacial Syndrome Genetic Test sale cost 4400 AED LRIG2 Gene Urofacial Syndrome Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
HLA - Narcolepsy DRB115 DQB10602 DQA1*0102 Test sale cost 1450 AED HLA - Narcolepsy DRB115 DQB10602 DQA1*0102 Test Cost 1,610 د.إ Original price was: 1,610 د.إ.1,450 د.إCurrent price is: 1,450 د.إ.
Sale!

FBN1 Gene Weill-Marchesani Syndrome Dominant Type 2 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The FBN1 Gene Weill-Marchesani Syndrome Dominant Type 2 Genetic Test is a specialized diagnostic tool used to identify mutations in the FBN1 gene, which are associated with Weill-Marchesani Syndrome (WMS) type 2. This rare genetic disorder is characterized by short stature, brachydactyly (short fingers), reduced joint flexibility, and eye abnormalities, among other symptoms. The dominant inheritance pattern of this type means that a mutation in just one of the two copies of the FBN1 gene can cause the disorder.

The test is crucial for individuals with a family history of WMS or those showing symptoms, as an early and accurate diagnosis can lead to better management of the condition. Conducted at DNA Labs UAE, a leading facility in genetic testing, the test involves analyzing the patient’s DNA to look for specific mutations in the FBN1 gene that are known to cause the syndrome.

The cost of the FBN1 Gene Weill-Marchesani Syndrome Dominant Type 2 Genetic Test is 4400 AED. While the price may seem high, the test provides invaluable information for affected individuals and their families, including insights into treatment options, management strategies, and genetic counseling for future family planning.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

FBN1 Gene Weill-Marchesani Syndrome Dominant Type 2 Genetic Test

Welcome to DNA Labs UAE, where we offer the FBN1 Gene Weill-Marchesani Syndrome Dominant Type 2 Genetic Test. This test is designed to analyze the FBN1 gene, which is associated with Weill-Marchesani syndrome, specifically the dominant type 2 form.

Test Components

  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test Type: Dysmorphology
  • Doctor: Pediatrics
  • Test Department: Genetics

Pre Test Information

Before undergoing the FBN1 Gene Weill-Marchesani Syndrome Dominant Type 2 Genetic Test, it is important to provide the clinical history of the patient who is going for the test. Additionally, a genetic counseling session may be conducted to draw a pedigree chart of family members affected with the syndrome.

Test Details

Weill-Marchesani syndrome is a rare connective tissue disorder characterized by short stature, joint stiffness, and various eye abnormalities. The FBN1 gene is specifically associated with the dominant type 2 form of this syndrome.

NGS (Next-Generation Sequencing) Genetic Testing is a technique used to analyze multiple genes simultaneously to identify genetic variations or mutations. In the context of Weill-Marchesani syndrome, NGS Genetic Testing can be used to identify specific mutations or variations in the FBN1 gene that are associated with the dominant type 2 form of the syndrome.

By analyzing the FBN1 gene, NGS Genetic Testing can provide valuable information for diagnosis, prognosis, and genetic counseling. It can help confirm the presence of the FBN1 gene mutation, guide appropriate medical management, and provide information about the likelihood of passing the condition to future generations.

It is important to note that NGS Genetic Testing should be performed by a qualified healthcare professional or genetic counselor, who can interpret the results and provide appropriate recommendations and support.

Test Name FBN1 Gene Weill-Marchesani syndrome dominant type 2 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Dysmorphology
Doctor Pediatrics
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for FBN1 Gene Weill-Marchesani syndrome, dominant type 2 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with FBN1 Gene Weill-Marchesani syndrome, dominant type 2 NGS Genetic DNA Test gene FBN1
Test Details

The FBN1 gene is associated with a genetic condition called Weill-Marchesani syndrome, specifically the dominant type 2 form. Weill-Marchesani syndrome is a rare connective tissue disorder characterized by short stature, joint stiffness, and various eye abnormalities.

NGS (Next-Generation Sequencing) Genetic Testing is a technique used to analyze multiple genes simultaneously to identify genetic variations or mutations. In the context of Weill-Marchesani syndrome, NGS Genetic Testing can be used to identify specific mutations or variations in the FBN1 gene that are associated with the dominant type 2 form of the syndrome.

By analyzing the FBN1 gene, NGS Genetic Testing can provide valuable information for diagnosis, prognosis, and genetic counseling. It can help confirm the presence of the FBN1 gene mutation, guide appropriate medical management, and provide information about the likelihood of passing the condition to future generations.

It is important to note that NGS Genetic Testing should be performed by a qualified healthcare professional or genetic counselor, who can interpret the results and provide appropriate recommendations and support.

SKU: TEST-4439 Category:

Related products